Latency-associated human cytomegalovirus glycoprotein N genotypes in monocytes from healthy blood donors

Transfusion

Volumn 46, Issue 10, 2006, Pages 1754-1762

  Pignatelli, Sara ^a   Dal Monte, Paola ^a   Rossini, Giada ^a   Camozzi, Daria ^a   Toscano, Vanda ^a   Conte, Roberto ^a   Landini, Maria Paola ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN N;

ADULT; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MONOCYTE; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; VIRUS DETECTION; VIRUS GENOME; VIRUS LATENCY;

ADULT; BLOOD DONORS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MONOCYTES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REFERENCE STANDARDS; SPECIES SPECIFICITY; VIRAL ENVELOPE PROTEINS; VIRUS LATENCY;

EID: 33748918774     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00963.x     Document Type: Article

References (47)

1. Britt WJ, Alford CA. Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. 3rd ed. Philadelphia: Lippincott-Raven; 2001.
2. Goodrum FD, Jordan CT, High K, Shenk T. Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci U S A 2002;99:16255-60.
3. Sinzger C, Grefte A, Plachter B, et al. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 1995;76:741-50.
4. Boeckh M, Hoy C, Torok-Storb B. Occult cytomegalovirus infection of marrow stroma. Clin Infect Dis 1998;26:209-10.
5. Taylor-Wiedeman J, Sissons P, Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 1994;68:1597-604.
6. von Laer D, Serr A, Meyer-Konig U, et al. Human cytomegalovirus immediate early and late transcripts are expressed in all major leukocyte populations in vivo. J Infect Dis 1995;172:365-70.
7. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A 1998;95:3937-42.
8. Roback JD. CMV and blood transfusions. Rev Med Virol 2002;12:211-9.
9. Khaiboullina SF, Maciewski JP, Crapnell K, et al. Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Br J Haematol 2004;126:410-7.
10. Hume DA, Ross IL, Himes SR, et al. The mononuclear phagocyte system revisited. J Leukoc Biol 2002;72:621-7.
11. Jarvis MA, Nelson JA. Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol 2002;5:403-7.
12. Sinclair J, Sissons P. Latent and persistent infections of monocytes and macrophages. Intervirology 1996;39:293-301.
13. Sinzger C, Jahn G. Human cytomegalovirus cell tropism and pathogenesis. Intervirology 1996;39:302-19.
14. Saederup N, Lin YC, Dairaghi DJ, Schall TJ, Mocarski ES. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci U S A 1999;96:10881-6.
15. Smith MS, Bentz GL, Alexander S, Yurochko AD. Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol 2004;78:4444-53.
16. Bolovan-Fritts CA, Mocarski ES, Wiedeman JA. Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 1999;93:394-8.
17. Slobedman B, Mocarski ES. Quantitative analysis of latent human cytomegalovirus. J Virol 1999;73:4806-12.
18. Soderberg-Naucler C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from blood donors. Cell 1997;91:119-26.
19. Roback JD, Bray RA, Hillyer CD. Longitudinal monitoring of WBC subsets in packed RBC units after filtration: implications for transfusion transmission of infections. Transfusion 2000;40:500-6.
20. Roback JD, Hillyer CD, Drew WL, et al. Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion 2001;41:1249-57.
21. Streblow DN, Nelson JA. Models of HCMV latency and reactivation. Trends Microbiol 2003;11:293-5.
22. Ljungman P. Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction. Br J Haematol 2004;125:107-16.
23. Pignatelli S, Dal Monte P, Rossini G, Landini MP. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 2004;14:383-410.
24. Dal Monte P, Pignatelli S, Mach M, Landini MP. The product of human cytomegalovirus UL73 is a new polymorphic structural glycoprotein (gpUL73). J Hum Virol 2001;4:26-34.
25. Pignatelli S, Dal Monte P, Landini MP. gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes. J Gen Virol 2001;82:2777-84.
26. Pignatelli S, Dal Monte P, Rossini G, et al. Glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 2003;84:647-55.
27. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-18.
28. Rossini G, Pignatelli S, Dal Monte P, et al. Monitoring for human cytomegalovirus infection in solid organ transplant recipients through antigenemia and glycoprotein N (gN) variants: evidence of correlation and potential prognostic value of gN genotypes. Microbes Infect 2005;7:890-6.
29. Demmler GJ, Buffone GJ, Schimbor CM, May RA. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis 1988;158:1177-84.
30. Fenner TE, Garweg J, Hufert FT, Boehnke M, Scmhitz H. Diagnosis of human cytomegalovirus-induced retinitis in human immunodeficiency virus type 1-infected subjects by using the polymerase chain reaction. J Clin Microbiol 1991;29:2621-2.
31. Pignatelli S, Dal Monte P, Rossini G, et al. Intrauterine cytomegalovirus infection and glycoprotein N (gN) genotypes. J Clin Virol 2003;28:38-43.
32. Pignatelli S, Dal Monte P, Rossini G, Gatto MR, Landini MP. Human cytomegalovirus glycoprotein N (gN) genotypes in AIDS patients. AIDS 2003;17:761-3.
33. Erlich HA. PCR technology: principles and applications for DNA amplification. Hampshire (UK): Stockton Press; 1989:31-38.
34. Dal Monte P, Pignatelli S, Rossini G, Landini MP. Genomic variants among human cytomegalovirus (HCMV) clinical isolates: the glycoprotein N (gN) paradigm. Hum Immunol 2004;65:387-94.
35. Mattick C, Dewin D, Polley S, et al. Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection. Virology 2004;318:582-97.
36. Kondo K, Kaneshima H, Mocarski ES. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A 1994;91:11879-83.
37. Jenkins K, Abendroth A, Slobedman B. A novel viral transcript with homology with human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 2004;78:1440-7.
38. Kondo K, Xu J, Mocarski ES. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A 1996;93:11137-42.
39. Roback JD, Drew WL, Laycock ME, et al. CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion 2003;43:314-21.
40. Soderberg Naucler C, Streblow DN, Fish KN, et al. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol 2001;75:7543-54.
41. Reeves MB, Lehner PJ, Sissons JG, Sinclair JH. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J Gen Virol 2005;86:2949-54.
42. Greenlee DJ, Fan H, Lawless K, Harrison CR, Gulley ML. Quantitation of CMV by real-time PCR in transfusable RBC units. Transfusion 2001;42:403-8.
43. Rahbar AR, Sundqvist VA, Wirgart BZ, Grillner LC, Soderberg-Naucler C. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood-donors. Transfusion 2004;44:1059-66.
44. Roback JD, Conlan M, Drew WL, et al. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections. Transfus Med Rev 2006;20:45-56.
45. Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 2005;102:4140-5.
46. Gerna G, Percivalle E, Sarasini A, Revello MG. The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko-(neutrophil- and monocyte-) tropism in vitro. J Gen Virol 2002;83:1993-2000.
47. Gerna G, Percivalle E, Sarasini A, et al. Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells. J Gen Virol 2003;84:1431-6.